An Exploratory Study on the Efficacy and Safety of Abatacept in the Treatment of Refractory Dermatomyositis

NCT04946669 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Dermatomyositis
Abatacept

Interventions

DRUG: Abatacept

Sponsor

The First Affiliated Hospital with Nanjing Medical University

Collaborators

[object Object]